CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
91526-18-0 | 4-(羟甲基)-5-甲基-[1,3]二氧杂环戊烯-2-酮 | 4-(hydroxymethyl)-5-methyl-[1,3]dioxol-2-one | C5H6O4 | 130.10 | | |
91526-42-0 | | 4-Methyl-2-propylpentanal | C9H18O | 142.24 | | |
91526-46-4 | | 2-Ethyl-4-methylhexanal | C9H18O | 142.24 | | |
91526-57-7 | | 2-Ethyl-2,4-dimethylpentanal | C9H18O | 142.24 | | |
91528-28-8 | | piperazine, 1-(10,11-dihydro-2-fluoro-8-(1-methylethyl)dibenzo(b,f)thiepin-10-y | | | | |
91528-30-2 | | piperazine, 1-(2-chloro-10,11-dihydro-8-(1-methylethyl)dibenzo(b,f)thiepin-10-y | | | | |
91528-31-3 | | piperazine, 1-(2-bromo-10,11-dihydro-8-(1-methylethyl)dibenzo(b,f)thiepin-10-yl | | | | |
91528-32-4 | | 1-piperazineethanol, 4-(10,11-dihydro-2-fluoro-8-(1-methylethyl)dibenzo(b,f)thi | | | | |
91528-33-5 | | 1-piperazineethanol, 4-(2-chloro-10,11-dihydro-8-(1-methylethyl)dibenzo(b,f)thi | | | | |
91528-34-6 | | 1-piperazineethanol, 4-(2-bromo-10,11-dihydro-8-(1-methylethyl)dibenzo(b,f)thie | | | | |
91528-35-7 | | 1-piperazineethanol, 4-(10,11-dihydro-2-iodo-8-(1-methylethyl)dibenzo(b,f)thiep | | | | |
915280-81-8 | 4-(2-(2,2,2-三氟乙酰基)肼基)苯磺酰胺 | 4-(2-(2,2,2-Trifluoroacetyl)hydrazinyl)benzenesulfonamide | C8H8F3N3O3S | 283.23 | | |
915288-13-0 | | meperfluthrin | | | | |
915289-60-0 | 蜂斗菜内酯IIIa | Bakkenolide IIIa | C24H32O6S | 448.57 | | 574.0±50.0 °C at 760 mmHg |
915296-00-3 | Elotuzumab单抗 | Elotuzumab | | | | |
915296-01-4 | | (2S,5S)-1-(11bs)-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphe | C36H28NO2P | 537.5868 | | |
915299-24-0 | 氯[三(2,4-二叔丁基苯基)亚磷酸]金 | chloro[tris(2,4-di-tert-butylphenyl)phosphite]gold | C42H63AuClO3P | 879.34 | 200-202°C | |
915299-32-0 | 4-氰基-3-三氟甲基苯硼酸 | 4-cyano-3-(trifluoromethyl)phenylboronic acid | C8H5BF3NO2 | 214.94 | | |
915302-21-5 | 2-氯吡啶并[3,2-d]嘧啶 | 2-Chloropyrido[3,2-d]pyrimidine | C7H4ClN3 | 165.5798 | | |
915303-09-2 | Indotecan(LMP400) | | C26H26N2O7 | 478.501 | | |
91531-30-5 | | antineoplaston a10 | C13H14N2O3 | 246.26 | | |
91531-98-5 | | amphethinile | | | | |
915314-13-5 | (S)-2-([2,2'-联吡啶]-6-基)-4-苯基-4,5-二氢恶唑 | (S)-2-([2,2'-Bipyridin]-6-yl)-4-phenyl-4,5-dihydrooxazole | C19H15N3O | 301.34 | | |
91532-02-4 | | 3-benzotriazin-4(3h)-one, 3-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-2 | | | | |
91532-11-5 | | 3-benzotriazin-4(3h)-one, 3-(3-(4-(3-fluorophenyl)-1-piperazinyl)propyl)-2 | | | | |
91532-12-6 | | 2,3-benzotriazin-4(3h)-one, 3-(3-(4-phenyl-1-piperazinyl)propyl)- monohydroc | | | | |
91532-22-8 | | 3-benzotriazin-4(3h)-one, 3-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-6-2 | | | | |
91532-26-2 | | thieno(2,3-d)-1,2,3-triazin-4(3h)-one, 3-(3-(4-(3-chlorophenyl)-1-piperazinyl)p | | | | |
91532-90-0 | | 5-a)pyrazin-3(2h)-one, hexahydro-2,7-diphenyl-imidazo( | | | | |
91532-91-1 | | 5-a)pyrazin-3(2h)-one, hexahydro-2-(3-methylphenyl)-7-phenyl-imidazo( | | | | |
91532-92-2 | | 5-a)pyrazin-3(2h)-one, hexahydro-2-(3-chlorophenyl)-7-phenyl-imidazo( | | | | |
91532-93-3 | | 5-a)pyrazin-3(2h)-one, hexahydro-2-(4-methoxyphenyl)-7-phenyl-imidazo( | | | | |
91532-98-8 | | 5-a)pyrazin-3(2h)-one, hexahydro-2-methyl-7-phenyl-imidazo( monohydrochlorid | | | | |
91533-00-5 | | 5-a)pyrazin-3(2h)-one, hexahydro-7-phenyl-2-(2-propenyl)-imidazo( monohydroc | | | | |
91533-02-7 | 2-(吡咯烷-1-基)-N-(4-氨磺基苯基)乙酰胺 | 2-(Pyrrolidin-1-yl)-N-(4-sulfamoylphenyl)acetamide | C12H17N3O3S | 283.35 | | |
91533-21-0 | | 5,6-dihydrothieno[2,3-d]pyridazine-4,7-dione | | | | |
91533-26-5 | | Boranamine,1-chloro-N,1-bis(1-methylethyl)- | C6H15BClN | 147.45 | | |
91533-35-6 | | Boranediamine,1-butyl-N'-(1,1-dimethylethyl)-N,N-diethyl- | C12H29BN2 | 212.18 | | |
915358-85-9 | 1-乙烯基-3-丁基咪唑六氟磷酸盐 | 1-butyl-3-vinylimidazolium hexafluorophosphate | C9H15F6N2P | 296.19 | | |
915363-56-3 | Cot inhibitor-2 | | C26H25Cl2FN8 | 539.43 | | |
915364-18-0 | 6-氨基-8-氯-4-[(3-氯-4-氟苯基)氨基]-3-喹啉甲腈 | 6-amino-8-chloro-4-((3-chloro-4-fluorophenyl)amino)quinoline-3-carbonitrile | C16H9Cl2FN4 | 347.17 | | |
915365-57-0 | Cot inhibitor 1 | | C27H27Cl2FN8 | 553.46 | | |
915369-16-3 | | ethyl 2-cyano-3-((2-(dimethylcarbamoyl)-4-nitrophenyl)imino)propanoate | | | | |
915369-22-1 | 8-Bromo-4-chloro-6-nitro-3-quinolinecarbonitrile | | C10H3BrClN3O2 | 312.5 | | |
915369-45-8 | 8-氯-4-羟基-6-硝基喹啉-3-甲腈 | 8-Chloro-6-nitro-4-oxo-1H-quinoline-3-carbonitrile | C10H4ClN3O3 | 249.61 | | 497.6±45.0 °C |
915369-46-9 | 4,8-二氯-6-硝基喹啉-3-甲腈 | 4,8-dichloro-6-nitroquinoline-3-carbonitrile | C10H3Cl2N3O2 | 268.06 | | |
915369-47-0 | 8-氯-4-((3-氯-4-氟苯基)氨基)-6-硝基喹啉-3-甲腈 | 8-chloro-4-((3-chloro-4-fluorophenyl)amino)-6-nitroquinoline-3-carbonitrile | C16H7Cl2FN4O2 | 377.16 | | |
915369-85-6 | 8-Fluoro-1,4-dihydro-6-nitro-4-oxo-3-quinolinecarbonitrile | | C10H4FN3O3 | 233.2 | | |
915369-86-7 | 4-Chloro-8-fluoro-6-nitro-3-quinolinecarbonitrile | | C10H3ClFN3O2 | 251.6 | | |
915369-88-9 | 3-Quinolinecarbonitrile, 6-amino-4-[(3-chloro-4-fluorophenyl)amino]-8-fluoro- | | C16H9ClF2N4 | 330.7 | | |